The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on November 26 2021 for RPR Sons Advisors Pvt Ltd P Suneela (jointly holding)
26-Nov-2021
Download PDF
Aurobindo Pharma
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on November 26 2021 for RPR Sons Advisors Pvt Ltd P Suneela (jointly holding)